Bourgeon Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
Bourgeon Capital Management's MDGL Position: Q3 2026 in Review
Bourgeon Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 20,095 shares worth $10.1M. The stake represents 1.45% of the portfolio and ranks #31 among its holdings.
442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Bourgeon Capital Management held 20,095 shares of Madrigal Pharmaceuticals worth $10.1M as of Q3 2026.
- Madrigal Pharmaceuticals was a new Bourgeon Capital Management position in Q3 2026.
- Madrigal Pharmaceuticals made up 1.45% of Bourgeon Capital Management's portfolio in Q3 2026, its #31 holding.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Bourgeon Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.